Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Single-Cell Omics Market?

In recent times, the market size for single-cell omics has experienced a significant escalation. The expectations are that it will escalate from $2.08 billion in 2024 to $2.39 billion in 2025, portraying a compound annual growth rate (CAGR) of 14.9%. The profound growth observed in the historic period could be credited to factors such as the discovery of cellular heterogeneity, the advent of tools for single cell analysis, advancements in biomedical research, characterization of the immune system, and the burgeoning field of precision medicine.

The market size of single-cell omics is projected to witness rapid expansion in the approaching years, expanding to $4.45 billion in 2029 with a compound annual growth rate (CAGR) of 16.8%. The surge during the forecast period can be ascribed to its clinical use and diagnosis, combined with multi-omics strategies, its implementation in regenerative medication, drug discovery and development, cell treatments, and immune therapies. Prominent trends during the forecast time frame encompass in vivo single-cell investigations, single-cell omics in research for infectious disease, microfluidics coupled with single-cell sorting, the integration of single-cell multi-omics, and spatial single-cell profiling.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Which Factor Is Shaping The Future Of The Single-Cell Omics Market?

The increase in cancer cases is projected to drive the expansion of the single-cell omics market. Cancer, a class of diseases that can occur in almost any organ or tissue when rogue cells multiply beyond control, breach their normal limits, and either spread to other organs or infiltrate adjacent body parts, has been a significant factor. The role of single-cell omics data has been instrumental in identifying cancer biomarkers, prognosis predictions, and the exploration of new therapeutic targets within set clinical cohorts. For illustration, the National Institutes of Health, a United States government agency, disclosed in May 2024 that as of January 2022, the United States had about 18.1 million people living as cancer survivors. This estimate is predicted to surge to 22.5 million by 2032. Therefore, the escalating incidence of cancer is pushing the growth of the single-cell omics market.

What Is The Segment-Wise Breakdown Of The Single-Cell Omics Market?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

Which Trends Are Redefining The Future Landscape Of The Single-Cell Omics Industry?

The incorporation of Artificial Intelligence (AI) within the drug discovery sector is becoming a prominent trend in the small-molecule drug discovery market. Major firms within this market are using AI as a tool to expedite their drug discovery processes and maintain a competitive edge. In May 2023, an illustration of this trend was seen when Google Cloud, Google’s cloud computing component based in the US, introduced the Target and Lead Identification Suite along with the Multiomics Suite. These initiatives aim to streamline drug discovery. The Multiomics Suite aids in the swift identification and analysis of genetic information, helping businesses to develop precision medicines. Meanwhile, the Target and Lead Identification Suite assists researchers to comprehend the function of amino acids and predict protein structures.

Which Companies Hold The Largest Market Share In The Single-Cell Omics Sector?

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

How Does Regional Performance Compare Across The Single-Cell Omics Industry?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model